HCW Biologics (HCWB) Debt to Equity (2022 - 2025)
Historic Debt to Equity for HCW Biologics (HCWB) over the last 4 years, with Q3 2025 value amounting to -$3.23.
- HCW Biologics' Debt to Equity fell 40796.36% to -$3.23 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.23, marking a year-over-year decrease of 40796.36%. This contributed to the annual value of -$0.93 for FY2024, which is N/A changed from last year.
- As of Q3 2025, HCW Biologics' Debt to Equity stood at -$3.23, which was down 40796.36% from -$123.55 recorded in Q2 2025.
- In the past 5 years, HCW Biologics' Debt to Equity ranged from a high of $1.02 in Q4 2022 and a low of -$123.55 during Q2 2025
- For the 4-year period, HCW Biologics' Debt to Equity averaged around -$11.64, with its median value being -$0.02 (2024).
- In the last 5 years, HCW Biologics' Debt to Equity soared by 57058.55% in 2024 and then plummeted by 62759689.11% in 2025.
- Over the past 4 years, HCW Biologics' Debt to Equity (Quarter) stood at $1.02 in 2022, then tumbled by 99.52% to $0.0 in 2023, then tumbled by 19016.72% to -$0.93 in 2024, then crashed by 246.36% to -$3.23 in 2025.
- Its Debt to Equity stands at -$3.23 for Q3 2025, versus -$123.55 for Q2 2025 and -$0.73 for Q1 2025.